Dr. Agarwal's Health Care IPO
Dr. Agarwal's Health Care IPO is priced at ₹382–₹402 per share with an issue size of ₹0 crore. The IPO opens on Jan 29, 2025 and closes on Jan 31, 2025, with a lot size of 35 shares and a minimum investment of ₹14,070.
Dr. Agarwal's Health Care Limited IPO
- IPO Dates
- Jan 29, 2025 – Jan 31, 2025
- Price band
- ₹382-402 per equity share
- Minimum Investment
- ₹14,070
- Issue size
- ₹0 Cr
- Lot size
- 35
- Allotment Date
- Feb 3, 2025
- Listing
- Feb 5, 2025
- Listing At
- BSE, NSE
IPO timeline
-
Jan 29, 2025
Open Date
Completed
-
Jan 31, 2025
Close Date
Completed
-
Feb 3, 2025
Allotment Date
Completed
-
Feb 5, 2025
Listing Date
Completed
Dr. Agarwal's Health Care IPO Expected Premium (Grey Market Trend)
Dr. Agarwal's Health Care IPO GMP today is ₹8. Grey market premium (GMP) indicates expected listing sentiment.
Dr. Agarwal's Health Care IPO expected premium (also known as grey market premium or GMP) indicates current market sentiment and potential listing expectations.
Expected Premium provided in this website is derived from market rumors. It is not a guaranteed indicator of the actual listing price and should be interpreted with caution.
Dr. Agarwal's Health Care IPO Live Subscription Details
View Subscription DetailsDr. Agarwal's Health Care IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Dr. Agarwal's Health Care IPO Essentials
Dr. Agarwal's Health Care IPO Details
Dr. Agarwal's Health Care IPO is priced at ₹382-402 per share with a total issue size of Total ₹3,027.76 Cr : #Fresh Issue : 74,62,686 shares(aggregating up to ₹300.00 Cr) + #OFS : 6,78,42,284 shares of ₹1(aggregating up to ₹2,727.26 Cr). The IPO has a lot size of 35 shares and will be listed on BSE and NSE.
- Issue price
- ₹382-402 per equity share
- Lot size
- 35 shares
- Face value
- ₹1 Per Equity Share
- Issue size
- Total ₹3,027.76 Cr :
#Fresh Issue : 74,62,686 shares(aggregating up to ₹300.00 Cr) +
#OFS : 6,78,42,284 shares of ₹1(aggregating up to ₹2,727.26 Cr) - Listing at
- BSE, NSE
- Listing date
- Registrar
- Kfin Technologies Limited
- Lead manager
-
Kotak Mahindra Capital Company Limited/nMorgan Stanley India Company Pvt Ltd, Jefferies India Private Limited, Motilal Oswal Investment Advisors Limited
Dr. Agarwal's Health Care IPO Reservation
Dr. Agarwal's Health Care IPO reservation details show category-wise allocation of shares. Out of the total NA shares, approximately 0% are reserved for QIB, 0% for NII, 0% for retail investors, and 0% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | NA (NA%) | |
| QIB Shares Offered | NA (NA%) | |
| NII (HNI) Shares Offered | NA (NA%) | |
| bHNI > ₹10L | NA (NA%) | |
| sHNI < ₹10L | NA (NA%) | |
| Retail Shares Offered | NA (NA%) | |
| Total Shares Offered | NA (NA%) |
Dr. Agarwal's Health Care IPO Analytics
Dr. Agarwal's Health Care Valuations
Earnings
- EPS Pre IPO
- ₹3.08/-
- EPS Post IPO
- ₹2.51/-
- P/E Pre IPO
- 130.44
- P/E Post IPO
- 160.48
Returns
- ROE
- 9.33%
- ROCE
- 14.61%
- RoNW
- 6.21%
- PAT Margin
- 6.90
Fundamentals
- Price / Book
- 7.96
Dr. Agarwal's Health Care Financials( In Crs.)
| 30-Sep-24 | 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|---|
| Assets | 3,393.41 | 2,752.82 | 1,825.17 | 1,026.13 |
| Revenue | 837.94 | 1,376.45 | 1,031.49 | 713.78 |
| Profit After Tax | 39.56 | 95.05 | 103.23 | 43.16 |
| Net Worth | 1,502.67 | 1,337.68 | 627.83 | 212.34 |
| Reserves & Surplus | 1,509.11 | 1,365.86 | 652.63 | 236.27 |
| Total Borrowing | 373.68 | 387.79 | 356.18 | 290.18 |
Dr. Agarwal's Health Care Company & Offer Insights
About Dr. Agarwal's Health Care
Established in 2010, Dr. Agarwal's Health Care Limited delivers a wide-ranging service of ophthalmic solutions, including cataract and refractive surgery, consultation and diagnosis, and non-surgical treatments, sales of optical goods, contact lenses, accessories, and pharmaceutical drugs related to eyes.
As of September 30, 2024, the company had 737 doctors treating patients in its facilities. During the same period, the company treated 2.13 million patients and performed 220,523 surgeries. For the six months ended September 30, 2024, they treated 1.15 million patients and performed 140,787 surgeries.
The Services offered by the company are:
Cataract surgeries; Provide cataract surgical services in its own facilities, which include small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments;
Refractive surgeries: These are surgeries used to correct the refractive errors of the eyes, helping a person decrease their dependence on eyeglasses or contact lenses. The major categories are LASIK, SMILE, implantable collamer lenses, and photorefractive keratectomy (PRK).
Other surgeries: Provide a number of other surgical interventions for ocular diseases, like surgical retinal interventions, corneal transplantation and pinhole pupilloplasty, oculoplasty and surgeries to treat glaucoma and pterygium.
By September 30, 2024, the company's Indian network includes 28 hubs (Tertiary Facilities, three COEs included) and 165 spokes (53 Primary and 112 Secondary Facilities).As on September 30, 2024, the Company has operations in India across 117 metro and non-metro cities in 14 states and four union territories through 193 Facilities.
Dr. Agarwal's Health Care Promoter(s)
Dr. Amar Agarwal, Dr. Athiya Agarwal, Dr Adil Agarwal, Dr. Anosh Agarwal, Dr Ashvin Agarwal, Dr. Ashar Agarwal, Dr. Amar Agarwal Family Trust, Dr Adil Agarwal Family Trust, Dr. Anosh Agarwal Family Trust, Dr Ashvin Agarwal Family Trust, Dr. Ashar Agarwal Family Trust, Dr Agarwal’s Eye Institute and Dr Agarwal's Eye Institute Private Limited are the company's promoters of Dr. Agarwal's Health Care.
Dr. Agarwal's Health Care IPO Issue Objectives
- •
- Repayment/prepayment, in part or full, of certain of the borrowings
- •
- General corporate purposes and unidentified inorganic acquisition.
Dr. Agarwal's Health Care IPO - Anchor Investors
Dr Agarwal's Health Care raises ₹875.50 crore from anchor investors.
Key foreign and domestic institutions, such as the Government of Singapore, Monetary Authority of Singapore, Government Pension Fund Global, and Fidelity, participated in the anchor round.
Other prominent investors were Invesco India Midcap Fund, The Nomura Trust, Ashoka Whiteoak MF, Motilal Oswal Small Cap Fund, Canara Robeco MF, VQ Fastercap Fund, The Prudential Assurance Co, HSBC Global Investment Fund, 360 One Equity Opportunity Fund, and Goldman Sachs (Singapore) PTE – ODI. Domestic names include LIC MF, Tata MF, Edelweiss MF, Axis Max Life, Aditya Birla Life, and Edelweiss Life Insurance as part of the anchor allocation.
Contact Information
Contact Details
Dr. Agarwal's Health Care
+91 44 4378 7777
1 st Floor, Buhari Towers, No.4, Moores Road, Off Greams Road, Near Asan Memorial School, Chennai 600 006
Registrar Contact Details
Kfin Technologies Limited
04067162222, 04079611000
Frequently Asked Questions
Click any question to reveal the answer
Dr. Agarwal's Health Care IPO is a book-built IPO worth ₹Total ₹3,027.76 Cr : #Fresh Issue : 74,62,686 shares(aggregating up to ₹300.00 Cr) + #OFS : 6,78,42,284 shares of ₹1(aggregating up to ₹2,727.26 Cr). The price band is ₹382–₹402 per share. The IPO opens on Jan 29, 2025 and closes on Jan 31, 2025. It will be listed on BSE and NSE. Kfin Technologies Limited is the registrar.
The price band of Dr. Agarwal's Health Care IPO is ₹382 to ₹402 per share.
The lot size of Dr. Agarwal's Health Care IPO is 35 shares.
The minimum investment for Dr. Agarwal's Health Care IPO is approximately ₹14,070 based on the upper price band .
Dr. Agarwal's Health Care IPO opens on Jan 29, 2025 and closes on Jan 31, 2025.
The allotment date of Dr. Agarwal's Health Care IPO is Feb 3, 2025.
Dr. Agarwal's Health Care IPO is expected to be listed on Feb 5, 2025, on BSE and NSE .
The Grey Market Premium (GMP) for Dr. Agarwal's Health Care IPO is ₹8-10 as of Jan 29, 2025. Based on the upper price band of ₹402, the estimated listing price is ₹410, representing a potential gain of approximately 2%.
Dr. Agarwal's Health Care IPO valuation snapshot: P/E 160.48, EPS ₹2.51/-, P/B 7.96, RoNW 6.21%, and market cap N/A.
To apply for Dr. Agarwal's Health Care IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Dr. Agarwal's Health Care IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Dr. Agarwal's Health Care IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Dr. Agarwal's Health Care IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Dr. Agarwal's Health Care IPO allotment status on IPO Ji for quick and easy access.